nicotinell fruit lyfjatyggigúmmí 2 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 2 mg
nicotinell fruit lyfjatyggigúmmí 4 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 4 mg
nicotinell icemint lyfjatyggigúmmí 2 mg
haleon denmark aps - nicotinum polacrillin - lyfjatyggigúmmí - 2 mg
pemetrexed wh (pemetrexed synthon) innrennslisþykkni, lausn 25 mg/ml
williams & halls ehf. - pemetrexedum inn - innrennslisþykkni, lausn - 25 mg/ml
penthrox innöndunargufa, gegndreyptur stabbi 3 ml
medical developments ned b.v. - methoxyflurane - innöndunargufa, gegndreyptur stabbi - 3 ml
pneumovax stungulyf, lausn í áfylltri sprautu 25 míkróg
merck sharp & dohme b.v. - pneumococcal polysaccharide danish types 1,2,3,4,5,6b,7f,8,9n,9v,10a,11a,12f,14,15b,17f,18,c,19a, 19f,20,22f,23f,33f - stungulyf, lausn í áfylltri sprautu - 25 míkróg
opzelura
incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - aðrar húðsjúkdómar - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.
typhim vi stungulyf, lausn 25 míkróg/0,5 ml
sanofi pasteur* - salmonella typhi vi antigen - stungulyf, lausn - 25 míkróg/0,5 ml
pentavac stungulyfsstofn og dreifa, dreifa
sanofi pasteur* - filamentous haemagglutinin; poliovirus inactivated type 2; poliovirus inactivated type 3; diphtheria toxoid; tetanus toxoid; poliovirus inactivated type 1; pertussis toxoid; haemophilus influenzae type b - stungulyfsstofn og dreifa, dreifa
ogluo
tetris pharma b.v - glúkagon - sykursýki - brisi hormón, glycogenolytic hormón - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.